Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced-intensity conditioning regimen and alemtuzumab

K. Matthews; Z. Lim; L. Pearce; A. Pagliuca; A. Madrigal; G. Mufti; L. Barber

Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced-intensity conditioning regimen and alemtuzumab

K. Matthews, Z. Lim, L. Pearce, A. Pagliuca, A. Madrigal, G. Mufti, L. Barber

Laws

Research output: Contribution to journal › Meeting abstract

13 Citations (Scopus)

Original language	English
Pages (from-to)	S203 - S203
Number of pages	11
Journal	Bone Marrow Transplantation
Volume	45
Issue number	6
Publication status	Published - Jun 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Matthews, K., Lim, Z., Pearce, L., Pagliuca, A., Madrigal, A., Mufti, G., & Barber, L. (2010). Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced-intensity conditioning regimen and alemtuzumab. Bone Marrow Transplantation, 45(6), S203 - S203.

Matthews, K. ; Lim, Z. ; Pearce, L. et al. / Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced-intensity conditioning regimen and alemtuzumab. In: Bone Marrow Transplantation. 2010 ; Vol. 45, No. 6. pp. S203 - S203.

@article{e11ca038a3a84068aa13e651530ab1ef,

title = "Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced-intensity conditioning regimen and alemtuzumab",

author = "K. Matthews and Z. Lim and L. Pearce and A. Pagliuca and A. Madrigal and G. Mufti and L. Barber",

year = "2010",

month = jun,

language = "English",

volume = "45",

pages = "S203 -- S203",

journal = "Bone Marrow Transplantation",

publisher = "Nature Publishing Group",

number = "6",

}

Matthews, K, Lim, Z , Pearce, L, Pagliuca, A, Madrigal, A, Mufti, G & Barber, L 2010, 'Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced-intensity conditioning regimen and alemtuzumab', Bone Marrow Transplantation, vol. 45, no. 6, pp. S203 - S203.

Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced-intensity conditioning regimen and alemtuzumab. / Matthews, K.; Lim, Z.; Pearce, L. et al.
In: Bone Marrow Transplantation, Vol. 45, No. 6, 06.2010, p. S203 - S203.

Research output: Contribution to journal › Meeting abstract

TY - JOUR

T1 - Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced-intensity conditioning regimen and alemtuzumab

AU - Matthews, K.

AU - Lim, Z.

AU - Pearce, L.

AU - Pagliuca, A.

AU - Madrigal, A.

AU - Mufti, G.

AU - Barber, L.

PY - 2010/6

Y1 - 2010/6

M3 - Meeting abstract

VL - 45

SP - S203 - S203

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 6

ER -

Matthews K, Lim Z , Pearce L, Pagliuca A, Madrigal A, Mufti G et al. Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced-intensity conditioning regimen and alemtuzumab. Bone Marrow Transplantation. 2010 Jun;45(6):S203 - S203.